CluePoints’ Unified RBQM Platform for Faster, Evidence-Based Clinical Trial Monitoring

CluePoints Risk-Based Quality Management (RBQM) is the intelligence layer that turns RBQM from a one-time assessment into a live, operational process. It connects study-level risk detection and central analytics with site-level prioritization and action, so Sponsors and CROs can detect issues earlier, focus monitoring where it matters most, and demonstrate ICH E6(R3)/E8(R1)-aligned oversight with confidence.

See how CluePoints enables regulatory-grade RBQM in practice.

Request Your Personalized RBQM Demo

ICH E6(R3): Redefining Quality & Oversight

ICH E6(R3) reframes Good Clinical Practice (GCP) as a principles-based framework rather than a checklist of activities, focusing on clear rationale, proportionate decisions, and traceable follow-through. Instead of prescribing how oversight must be performed, it defines what must be achieved:

  • Quality designed into trials from the outset
  • Oversight proportionate to risk
  • Decisions that are justified, documented, and traceable

The Outcomes That Define Effective RBQM

CluePoints enables regulatory-grade RBQM by turning risk signals into earlier insights, smarter decisions, and fully traceable, inspection-ready oversight.

Regulatory-Grade RBQM Execution

Operationalize RBQM with structured, CtQ-driven risk frameworks, fully traceable KRIs and QTLs, and a complete thread from risk identification to documented action.

Earlier Detection of Issues That Matter

Continuously monitor clinical, operational, and site-level data to uncover meaningful patterns, outliers, and emerging risks before they escalate into protocol deviations or inspection findings.

Leaner On-Site Effort

Prioritize sites using multi-factor risk scoring and clear rationale, enabling targeted monitoring strategies that reduce unnecessary on-site effort while protecting patient safety and data quality.

Unified Oversight with Inspection-Ready Evidence

Align cross-functional teams around a single view of risk, with every signal, decision, and action captured to support a clear, defensible inspection narrative.

Seamless Data Monitoring Workflow for Clinical Trial Management

CluePoints RBQM brings together the Central Monitoring Platform (CMP) and the Site Profile & Oversight Tool (SPOT) to deliver smarter, more efficient clinical trials.

Early, Evidence-Based Risk Detection

CMP detects study‑level risks, statistical anomalies, data integrity issues, and operational deviations.

AI-Enhanced, Future-Ready Oversight

SPOT identifies which sites require attention and why using multi‑factor operational risk scoring and cross‑domain insights.

Unified Intelligence Across Study & Site Operations

Together, they deliver end‑to‑end RBQM intelligence, from pattern detection to site action.

By combining study‑level data interrogation with site‑level operational intelligence, the platform transforms artificial intelligence into human intelligence, empowering teams to make faster, clearer, and more accurate decisions.

Driving Smarter Trials with CluePoints

CluePoints is the leader in RBQM solutions for clinical trials, transforming how clinical and operational teams collaborate through AI-powered workflows. CluePoints empowers Sponsors and CROs to move beyond disconnected tools toward a unified ecosystem that includes SPOT, Medical & Safety Review (MSR), Intelligent Medical Coding (IMC), and Intelligent Query Detection (IQD). Backed by expert consulting and industry-leading product innovation, CluePoints is advancing human intelligence to drive smarter, faster, and more connected clinical trials.